Table 3.

Means (95% confidence limits) for domiciliary diary card data for pooled placebo and each randomized treatment.

	Pooled placebo	Montelukast	Formoterol
PEFam (l min−1)	390 [375–400]	400 [390–415]	405 [390–415]
PEFpm (l min−1)	410 [400–425]	420 [410–430]	420 [400–425]
RESam (puffs 12 h−1)	3.6 [1.2–4.8]	2.4 [1.2–3.6]	2.4 [1.2–3.6]
RESpm (puffs 12 h−1)	4.4 [3.6–5.4]	2.6*[1.8–3.6]	2.8*[2.0–3.8]
SYMam (U 12 h−1)	0.8 [0.6–1.0]	0.7 [0.5–0.9]	0.8 [0.6–0.9]
SYMpm (U 12 h−1)	0.8 [0.6–1.0]	0.7 [0.5–0.9]	0.8 [0.6–0.9]

Means [95% confidence intervals] adenosine monophosphate PC₂₀ (AMP PC₂₀), exhaled nitric oxide (NO), blood eosinophil count (EOS), forced expiratory volume in 1 second (FEV₁), forced mid expiratory flow (FEF_25-75), laboratory peak expiratory flow (PEFlab), domiciliary morning/evening peak expiratory flow (PEFam/pm), daytime/night-time symptom score (SYMam/pm) and daytime/night-time rescue bronchodilator requirement (RESam/pm).

^*Denotes a significant difference between pooled placebo and randomized treatments.